Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Rankning i aktier #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Aktiekurs
$0.00162013
Senast synkroniserad: 2025-01-03
Marknadsvärde
$156.25K
Förändring (1 dag)
0.36%
Förändring (1 år)
0.00%
Land
SE
Handel Cyxone AB (publ) (CYXO)

Kategori

Aktiekurshistorik för Cyxone AB (publ) (CYXO)
Högsta slutkurs: $0.00 den 2025-01-01

Lägsta slutkurs: $0.50 den 2016-06-01
Aktiekurshistorik för Cyxone AB (publ) från 2016 till 2026
Årlig aktiekursutveckling
År Prestanda
2025 -8.09%
2024 -82.58%
2023 -77.33%
2022 -83.86%
2021 -39.25%
2020 12.33%
2019 61.54%
2018 -80.08%
2017 88.25%
2016 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE